PBH

Prestige Consumer Healthcare Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth↓ 1/10
  • Value↓ 3/10
Prestige Consumer Healthcare sales and earnings growth
PBH Growth
Low
  • Revenue Y/Y↓ 0.18%
  • EPS Y/Y↓ -9.03%
  • FCF Y/Y↓ 1.30%
Prestige Consumer Healthcare gross and profit margin trends
PBH Profitability
Good
  • Gross margin ↑ 54.70%
  • EPS margin↑ 17.50%
  • ROIC 5Y↑ 16.67%
Prestige Consumer Healthcare net debt vs free cash flow
PBH Risk
Great
  • Debt / Equity↓ 0.6
  • Debt / FCF↓ 4.0
  • Interest coverage↑ 7.1

Prestige Consumer Healthcare stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks